Bell Investment Advisors, Inc Allakos Inc. Transaction History

Bell Investment Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$2.13 - $5.55 $283 - $738	-133 Reduced 63.33%	77 $0
Q2 2023 Aug 09, 2023	BUY	$3.6 - $5.25 $370 - $540	103 Added 96.26%	210 $0
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $367 - $4,811	43 Added 67.19%	107 $1,000
Q3 2021 Nov 12, 2021	BUY	$76.53 - $110.43 $4,897 - $7,067	64 New	64 $7,000

66.9M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $22.9M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bell Investment Advisors, Inc with notifications on news.